KRT1 and fatty liver disease: Given that 18F-FDG K1 of liver was also demonstrated to associate with hepatic inflammation in fatty liver disease (9,45), the interplay between K1 and inflammation reaction and the potential of K1 as a biomarker of disease are worth more studies to explore clinical applications.